| NGDAX | RGEBX | NGDAX / RGEBX | |
| Total Expense Ratio | 1.02 | 1.08 | 94% |
| Annual Report Gross Expense Ratio | 1.02 | 1.08 | 94% |
| Fund Existence | 17 years | 11 years | - |
| Gain YTD | -2.460 | -1.057 | 233% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.56B | 336B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -3.68 | 1.80 | -205% |
| Returns for 3 years | 36.91 | 41.63 | 89% |
| Returns for 5 years | 17.50 | 9.88 | 177% |
| Returns for 10 years | 81.71 | 110.02 | 74% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MOORX | 17.30 | 0.06 | +0.35% |
| MassMutual Small Cap Opps R4 | |||
| VSFSX | 26.70 | 0.08 | +0.30% |
| Federated Hermes MDT Small Cap Value R6 | |||
| JFNNX | 81.67 | -0.52 | -0.63% |
| Janus Henderson Global Life Sciences N | |||
| UPAAX | 18.41 | -0.30 | -1.60% |
| Upright Assets Allocation Plus | |||
| IRLAX | 81.97 | -1.49 | -1.79% |
| Voya Russell Large Cap Growth Idx Port A | |||